Cassava sciences to present at svb leerink global healthcare conference

Austin, texas, feb. 23, 2021 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company developing product candidates for alzheimer's disease, has been invited to present at the 10th annual svb leerink global healthcare conference.
SAVA Ratings Summary
SAVA Quant Ranking